Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.6950 (1.28%) ($10.6950 - $10.6950) on Tue. Feb. 7, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.4% (three month average) | RSI | 62 | Latest Price | $10.6950(1.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(38%) XBI(31%) IBB(28%) SDY(27%) IFRA(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.7% in a week (0% probabilities). VIXM(-16%) UUP(-10%) VXX(-7%) TBT(-1%) TLT(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.7% (StdDev 3.4%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $10.62(0.71%) | 10 Day Moving Average | $10.6(0.9%) | 20 Day Moving Average | $10.48(2.05%) | To recent high | -22.4% | To recent low | 7% | Market Cap | $1.887b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |